BioGate USA, a Seattle based company started with a group
of people with diverse background including businessmen, biological and clinical scientists.
The founders of the BioGate possess own patents and technology. We are trying to expedite commercialization process of newly developed technology and products.
With rich R&D and marketing experience the company is also investing in research and development of new biotech projects such as new diagnostic kit, as well as formulate, manufacture nutritional supplement and alternative medicine products.
Currently, a number of patents are pending/approved and under development:
Patent: Method and apparatus to increase the public hygiene behavior. USA 2010
Patent: A Novel technology to increase the sensitivity and shorten the test turnaround time for TB diagnosis. China 2007
Patent: AI automated home environment test to prevent infectious diseases and save medical costs
It is well known that environmental factors, particularly microorganisms, have a significant impact on health. Numerous clinical studies have confirmed that microbial contamination in home environments is associated with the occurrence of various diseases, including asthma, allergies, certain infectious diseases, and cancer. To address this issue, China’s PRTCX Company has collaborated with the American BioGate Technology Company to develop a comprehensive AI assisted detection device for health-influencing factors in residential and public environments. (Patent No:CN202122585986.1) and conducted a six-month environmental microbial testing study involving 600 households, using the method of colony sedimentation experiments. The results indicated a clear correlation between the health status of family members and the concentration of microorganisms in the home environment, hospital visits and healthcare/medical costs. To learn more about our investment project, please contact us: 1205 S. Jackson St. Seattle, WA 98144 Email: support@biogate-usa.com www.biogate-usa.com Tel: 206-7788496
Patent: Method and apparatus to increase the public hygiene behavior. USA 2010
Patent: A Novel technology to increase the sensitivity and shorten the test turnaround time for TB diagnosis. China 2007
Patent: AI automated home environment test to prevent infectious diseases and save medical costs
It is well known that environmental factors, particularly microorganisms, have a significant impact on health. Numerous clinical studies have confirmed that microbial contamination in home environments is associated with the occurrence of various diseases, including asthma, allergies, certain infectious diseases, and cancer. To address this issue, China’s PRTCX Company has collaborated with the American BioGate Technology Company to develop a comprehensive AI assisted detection device for health-influencing factors in residential and public environments. (Patent No:CN202122585986.1) and conducted a six-month environmental microbial testing study involving 600 households, using the method of colony sedimentation experiments. The results indicated a clear correlation between the health status of family members and the concentration of microorganisms in the home environment, hospital visits and healthcare/medical costs. To learn more about our investment project, please contact us: 1205 S. Jackson St. Seattle, WA 98144 Email: support@biogate-usa.com www.biogate-usa.com Tel: 206-7788496